Pfizer Charged in Nigerian Children's Deaths

by Karen Hatter | May 30, 2007 at 08:28 pm
1235 views | 16 Recommendations | 7 comments

Photos

Viagra's new initiative

Viagra's new initiative

see larger image

uploaded by Lasadh

Nigerian officials have brought criminal charges against drug maker Pfizer Inc., the world's largest drug company, alleging the company's involvement in distributing an untested antibiotic, Trovan, during a meningitis outbreak in 1996. They have also filed a civil lawsuit seeking damages and restitution in the amount of 2 billion dollars.


200 children and infants were selected from a camp in the state of Kano, with half of the children given the untested antibiotic. The Nigerian government alleges the rest were given a low dose of a comparative drug made by Hoffman–La Roche.


The lawsuit states researchers did not obtain consent from the parents of the children and they were banned from the ward where the drugs were given. Nigerian officials say Pfizer's actions have resulted in unspecified deaths, with the surviving children, as a result of the drug, left deaf, paralyzed, blind or brain damaged.


Former Kano attorney general, Aliyu Umar has filed the charges with the support of federal and state authorities.


www.washingtonpost.com/wp-dyn/content/article/2007/05/29/AR2007052902107.html?referrer=email

Advertisement
recommend This comment thread is now closed
ScienceDave
ScienceDave
flagged this story as Good Stuff

at 20:54 on May 30th, 2007

Mega-corporations at their best! Good stuff!

3
Karen Hatter

Thank you, Nouseforadave!

3
Barry ORegan

Excellent story Karen, unfortunately we may experience the same from Pfizer as they are now in discussion with China to set up more drug manufacturing there, by outsourcing once again, not just our safety and health, but including our lifes.  Will melamine used by Chinese companies find its way in drugs as a cheap binder, just as they used in the recent pet foods, and salmon feed for salmon farms, who knows when profit overtakes people lives.  With the advent of Pfzier and their new outsourced companies in china, will this be the last we hear of future similar incidents like Nigeria involving Pfizer? 

Here is the news link to update your report Karen, for more on outsourcing , you should view my two recent Now Public stories on Air Canada outsourcing our Safety and Proudly outsourcing our Birthright. These two stories are quite an eye opener, especially customers and frequent flyers who may have to rethink flying with Air Canada

http://www.drugresearcher.com/news-by-product/news.asp?id=73673&idCat=17&k=Pfizer--outsourcing-manufacturing

3
Karen Hatter

Thank you for the info, Barry Artiste! As you most likely know, Pfizer isn't the only drug company engaged in these types of practices. We, as citizens and consumers, must be on alert and keep our eyes open!

3
Barry ORegan

Your welcome Karen, I just wonder having worked in Pharmaceutical Research (Cancer) if these Drug Companies outsource to China in order to circumvent (New Drug Applications) NDA submissions and FDA approvals, if these drugs do not end up in North America, but are used as clinical trials in third world countries where as guinea pigs, the drug companies  can see if their drugs are  effective or not, before applying for  FDA approval, as clinical trials are extremely expensive and can take up to 5-7 years before getting on the market.  Of course with internet pharmacies popping up and  drugs being mailed from China to the North American consumer, can North American consumers be assured if these same drugs do not end up in the North American market if they originate from China?  It begs the question, North American Consumers can successfully sue for negligence, where as Third world litigants may not be as successful.  In some cases, fast tracking drugs to market are used only in the case of epidemic or when the ailment is IDLH.   I can pretty much assure you GLP and GMP practices in China will never even come close to Western Societies. I could go on and on about this subject having worked on NDA and FDA submissions intensively, better for Now Public readers to just internet search for additional answers.

4
Karen Hatter

Barry, it has always been my principle position that since the deregulation of the drug industry in the U.S., shortening the lengthy trial study of new drugs, after the initial testing in the so called Third World and developing nations, the U.S. and other developed nations become yet another tier in the actual testing process.


It is my understanding that most clinical studies done overseas, done almost anywhere actually and as you stated, last less than 10 years. If that is the case, there aren't any long term statistics for any drug when it is introduced onto the market so, the populations of the entire world seem to have become guinea pigs, in most cases unknowingly, on separate rungs of the drug testing ladder!

5
Barry ORegan

The FDA will accept Fast Track submissions from Pharamceutical industries, reducing clinical trials, but these fast track processes are pretty strict and used for drugs to treat or cure deadly Cancers, TB, HIVAids, etc.  To get a fast track application approved by the FDA is hell on earth, you better have all your drugs and equipment validated and QA,QC and other processes scrutinised over and over again before called the FDA.  When FDA come a knocking on your door, they will go over everything and interrogate you so often, that it will seem like your head will implode.

One thing I have experienced when working with the FDA is their heart is in the right place, their dedication and expertise is above reproach in most cases. 

This story was created over 3 months ago, the comment thread is now closed.

NowPublic on Facebook

What is NowPublic?

NowPublic lets people work together to cover news events around the world.

Find out more

Crowd Power

ScienceDave
First Flagged at 8:53 PM, May 30, 2007 by ScienceDave
These members have powered this story:

Most Recommended Stories in World

Recommendations (16)

Most recently recommended by:
 

closeSign in to NowPublic

is reporting from